A new home for the IMP
Over the next two years a new, state-of-the-art research building for the IMP will take shape. This investment has been made possible by our main sponsor, Boehringer Ingelheim, which decided to allocate 50 million Euros to the future base of IMP research at the Vienna Biocenter. Only a stone’s throw away from its present premises, the construction of the new IMP building is underway.
Rendering: ATP/Telegram 71